Hhip haploinsufficiency sensitizes mice to age-related emphysema

Significance Genome-wide association studies (GWAS) have been very successful in discovering genetic loci associated with complex traits. However, only few studies applied murine models to investigate how GWAS genes contribute to human lung diseases. Motivated by GWAS linking Hedgehog interacting protein (HHIP) to emphysema and impairments in lung function, this study demonstrated that Hhip+/− mice developed spontaneous emphysema and lung function impairment over time. Moreover, emphysema, associated with increased oxidative stress in Hhip+/− lungs, was prevented by treating the mice with the antioxidant, N-acetyl cysteine (NAC). This post-GWAS functional study connects aging-related diseases, molecular mechanisms, and potential therapy in a genetic haploinsufficient murine model, which may lead to improvements in understanding pathophysiologic concepts of alveolar loss related to aging. Genetic variants in Hedgehog interacting protein (HHIP) have consistently been associated with the susceptibility to develop chronic obstructive pulmonary disease and pulmonary function levels, including the forced expiratory volume in 1 s (FEV1), in general population samples by genome-wide association studies. However, in vivo evidence connecting Hhip to age-related FEV1 decline and emphysema development is lacking. Herein, using Hhip heterozygous mice (Hhip+/−), we observed increased lung compliance and spontaneous emphysema in Hhip+/− mice starting at 10 mo of age. This increase was preceded by increases in oxidative stress levels in the lungs of Hhip+/− vs. Hhip+/+ mice. To our knowledge, these results provide the first line of evidence that HHIP is involved in maintaining normal lung function and alveolar structures. Interestingly, antioxidant N-acetyl cysteine treatment in mice starting at age of 5 mo improved lung function and prevented emphysema development in Hhip+/− mice, suggesting that N-acetyl cysteine treatment limits the progression of age-related emphysema in Hhip+/− mice. Therefore, reduced lung function and age-related spontaneous emphysema development in Hhip+/− mice may be caused by increased oxidative stress levels in murine lungs as a result of haploinsufficiency of Hhip.

[1]  Lloyd H. Michael,et al.  The Guide for the Care and Use of Laboratory Animals. , 2016, ILAR journal.

[2]  B. Celli,et al.  B Cell-Activating Factor. An Orchestrator of Lymphoid Follicles in Severe Chronic Obstructive Pulmonary Disease. , 2015, American journal of respiratory and critical care medicine.

[3]  I. Adcock,et al.  Influence of glutathione-S-transferase (GST) inhibition on lung epithelial cell injury: role of oxidative stress and metabolism. , 2015, American journal of physiology. Lung cellular and molecular physiology.

[4]  B. Moser CXCR5, the Defining Marker for Follicular B Helper T (TFH) Cells , 2015, Front. Immunol..

[5]  P. E. Van den Steen,et al.  CXCR3 ligands in disease and therapy. , 2015, Cytokine & growth factor reviews.

[6]  John Quackenbush,et al.  Haploinsufficiency of Hedgehog interacting protein causes increased emphysema induced by cigarette smoke through network rewiring , 2015, Genome Medicine.

[7]  J. Sznajder,et al.  Blue journal conference. Aging and susceptibility to lung disease. , 2015, American journal of respiratory and critical care medicine.

[8]  C. Owen,et al.  Automated measurement of pulmonary emphysema and small airway remodeling in cigarette smoke-exposed mice. , 2015, Journal of visualized experiments : JoVE.

[9]  A. Joyner,et al.  Roles for Hedgehog signaling in adult organ homeostasis and repair , 2014, Development.

[10]  Oliver Eickelberg,et al.  Cigarette smoke-induced iBALT mediates macrophage activation in a B cell-dependent manner in COPD. , 2014, American journal of physiology. Lung cellular and molecular physiology.

[11]  P. Kirkham,et al.  Oxidative stress in COPD. , 2013, Chest.

[12]  M. Peppelenbosch,et al.  Hedgehog signalling as an antagonist of ageing and its associated diseases , 2012, BioEssays : news and reviews in molecular, cellular and developmental biology.

[13]  D. Neureiter New in Hedgehog signaling: A possible role in aging, and chronic degenerative and inflammatory diseases? (Comment on DOI 10.1002/bies.201200049) , 2012, BioEssays : news and reviews in molecular, cellular and developmental biology.

[14]  Hongwei Yao,et al.  SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice. , 2012, The Journal of clinical investigation.

[15]  Edwin K Silverman,et al.  Identification of a chronic obstructive pulmonary disease genetic determinant that regulates HHIP. , 2012, Human molecular genetics.

[16]  Blair H. Smith,et al.  Effect of five genetic variants associated with lung function on the risk of chronic obstructive lung disease, and their joint effects on lung function. , 2011, American journal of respiratory and critical care medicine.

[17]  Christian Gieger,et al.  Genome-wide association and large scale follow-up identifies 16 new loci influencing lung function , 2011, Nature Genetics.

[18]  O. Firuzi,et al.  Antioxidant therapy: current status and future prospects. , 2011, Current medicinal chemistry.

[19]  P. Ingham,et al.  Mechanisms and functions of Hedgehog signalling across the metazoa , 2011, Nature Reviews Genetics.

[20]  C. Carlson,et al.  Principles for the post-GWAS functional characterization of cancer risk loci , 2011, Nature Genetics.

[21]  Konstantinos N Lazaridis,et al.  Genomics in the post-GWAS era. , 2011, Seminars in liver disease.

[22]  Hidetoshi Nakamura Genetics of COPD. , 2011, Allergology international : official journal of the Japanese Society of Allergology.

[23]  Inês Barroso,et al.  Genome-wide association study identifies five loci associated with lung function , 2010, Nature Genetics.

[24]  J. Martin,et al.  Births: final data for 2008. , 2010, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[25]  Jiaquan Xu,et al.  Deaths: preliminary data for 2008. , 2010, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[26]  M. Mendez,et al.  Dietary modulation of oxidative stress in chronic obstructive pulmonary disease patients , 2010, Free radical research.

[27]  D. Harrison,et al.  Faculty Opinions recommendation of CD8+ T Cells are required for inflammation and destruction in cigarette smoke-induced emphysema in mice. , 2010 .

[28]  Teri A Manolio,et al.  Genomewide association studies and assessment of the risk of disease. , 2010, The New England journal of medicine.

[29]  G. Gibson Hints of hidden heritability in GWAS , 2010, Nature Genetics.

[30]  A. Hofman,et al.  Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function , 2010, Nature Genetics.

[31]  K. Shianna,et al.  A Genome-Wide Association Study in Chronic Obstructive Pulmonary Disease (COPD): Identification of Two Major Susceptibility Loci , 2009, PLoS genetics.

[32]  Olaf Holz,et al.  Aging and induced senescence as factors in the pathogenesis of lung emphysema. , 2008, Respiratory medicine.

[33]  P. Barnes Frontrunners in novel pharmacotherapy of COPD. , 2008, Current opinion in pharmacology.

[34]  E. Oviedo-Orta,et al.  Comparison of MMP‐2 and MMP‐9 secretion from T helper 0, 1 and 2 lymphocytes alone and in coculture with macrophages , 2008, Immunology.

[35]  F. Sciurba,et al.  Autoantibodies in patients with chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.

[36]  W. Mitzner,et al.  Global expression profiles from C57BL/6J and DBA/2J mouse lungs to determine aging-related genes. , 2007, Physiological genomics.

[37]  Hongwei Yao,et al.  Future therapeutic treatment of COPD: Struggle between oxidants and cytokines , 2007, International journal of chronic obstructive pulmonary disease.

[38]  K. Aoshiba,et al.  Chronic lung inflammation in aging mice , 2007, FEBS letters.

[39]  H. Coxson,et al.  Antielastin autoimmunity in tobacco smoking–induced emphysema , 2007, Nature Medicine.

[40]  S. Ryter,et al.  Functional Significance of Apoptosis in Chronic Obstructive Pulmonary Disease , 2007, COPD.

[41]  I. Rahman Oxidative stress in pathogenesis of chronic obstructive pulmonary disease , 2007, Cell Biochemistry and Biophysics.

[42]  Patty J. Lee,et al.  Toll-like receptor 4 deficiency causes pulmonary emphysema. , 2006, The Journal of clinical investigation.

[43]  C. Vogelmeier,et al.  [Pathogenesis of chronic obstructive pulmonary disease]. , 2006, Der Internist.

[44]  Cheryl F. Lichti,et al.  Lifespan and stress resistance of Caenorhabditis elegans are increased by expression of glutathione transferases capable of metabolizing the lipid peroxidation product 4‐hydroxynonenal , 2005, Aging cell.

[45]  C. Owen Proteinases and oxidants as targets in the treatment of chronic obstructive pulmonary disease. , 2005, Proceedings of the American Thoracic Society.

[46]  P. Paré,et al.  The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[47]  A. McMahon,et al.  Feedback control of mammalian Hedgehog signaling by the Hedgehog-binding protein, Hip1, modulates Fgf signaling during branching morphogenesis of the lung. , 2003, Genes & development.

[48]  D. Postma,et al.  Chronic obstructive pulmonary disease. , 2002, Clinical evidence.

[49]  N J Wareham,et al.  Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. , 2001, American journal of respiratory and critical care medicine.

[50]  Pao-Tien Chuang,et al.  Vertebrate Hedgehog signalling modulated by induction of a Hedgehog-binding protein , 1999, Nature.

[51]  B Rosner,et al.  Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. , 1998, American journal of respiratory and critical care medicine.